CRSP CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

$95.09  -1.61 (-1.67%)
As of 10/26/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  10/19/2016
Outstanding shares:  76,201,185
Average volume:  1,781,387
Market cap:   $7,281,785,239
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    H17182108
ISIN:        CH0334081137
Sedol:      BDHF4K6
Valuation   (See tab for details)
PE ratio:   16.50
PB ratio:   2.83
PS ratio:   8.08
Return on equity:   17.15%
Net income %:   49.52%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy